Document is current
Any future updates will be listed below
-
Authors
Liu, Li
Yan, Ziyi
He, Fumei
Chen, Jie
Kuang, Linghan
Liu, Xingxin
Cui, Yali
Wang, Xia
Miao, Chenglin
Li, Hong
Jiang, Yongmei
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82102458, 82300015)
Northern Sichuan Medical College-level Scientific Research Development Fund Project (CBY21-QA02)
Sichuan Science and Technology Program (2024NSFSC1555, 2023NSFSC1699, 2024NSFSC1942, 2024YFFK0350, 2023YFS0223, 2023YFS0222)
Science and Technology Program of Sichuan Province (2022YFS0235)
National Key Research and Development Program of China (2024YFC2707405)
- License Information
-
More Information
Article History
Received: 10 September 2024
Accepted: 9 January 2025
First Online: 27 January 2025
Declarations
:
: The clinical experimental plan was approved by the Clinical Trial Ethics Committee of West China Second University Hospital, Sichuan University. The informed consent to adult participate was waived by the Clinical Trial Ethics Committee of West China Second University Hospital, Sichuan University according to Chinese government “Measures for the Ethical Review of Life Science and Medical Research Involving Human Beings” (Chapter III, Article 32, ). As for minors, informed consent was obtained from legal guardians on behalf of the minors involved in the study. The work was carried out in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
: Not applicable.
